Publications
Found 18 results
Filters: Author is J.L. Wang [Clear All Filters]
“Association of IL-1α gene polymorphism with susceptibility to type 1 diabetes in Chinese children”, vol. 15, p. -, 2016.
, “Association of IL-1α gene polymorphism with susceptibility to type 1 diabetes in Chinese children”, vol. 15, p. -, 2016.
, , , “Association of interleukin-1β -511C/T promoter polymorphism with COPD risk: a meta-analysis”, vol. 14, pp. 4477-4484, 2015.
, “Correlation between interleukin-6 expression in articular cartilage bone and osteoarthritis”, vol. 14, pp. 14189-14195, 2015.
, “Low-level sequence variation in Toxoplasma gondii calcium-dependent protein kinases among different genotypes”, vol. 14, pp. 4949-4956, 2015.
, “Matrix metalloproteinase-3 gene polymorphism and its mRNA expression in rheumatoid arthritis”, vol. 14, pp. 15652-15659, 2015.
, “Multidrug resistance gene (MDR1) polymorphisms may not be directly associated with response to imatinib in chronic myeloid leukemia”, vol. 14, pp. 14967-14978, 2015.
, “Polymorphisms in the bovine CIDEC gene are associated with body measurement traits and meat quality traits in Qinchuan cattle”, vol. 14, pp. 9013-9023, 2015.
, “TNF-αG-308A polymorphism is associated with insulin resistance: a meta-analysis”, vol. 14, pp. 563-573, 2015.
, “Effects of bovine SMO gene polymorphisms on the body measurement and meat quality traits of Qinchuan cattle”, vol. 13, pp. 8105-8117, 2014.
, “Molecular cloning and characterization of the pseudorabies virus UL31 gene”, vol. 13, pp. 1832-1847, 2014.
, “Multidrug resistance gene and its relationship to ulcerative colitis and immune status of ulcerative colitis”, vol. 13, pp. 10837-10851, 2014.
, “Changes of Th1/Th2 cytokines in immunocompetent patients with pulmonary cryptococcosis”, vol. 12, pp. 5733-5742, 2013.
, “SNPs at 3'-UTR of the bovine CDIPT gene associated with Qinchuan cattle meat quality traits”, vol. 12, pp. 775-782, 2013.
, Antonsson BE (1994). Purification and characterization of phosphatidylinositol synthase from human placenta. Biochem. J. 297 (Pt 3): 517-522.
PMid:8110188 PMCid:1137864
Brethour JR (1994). Estimating marbling score in live cattle from ultrasound images using pattern recognition and neural network procedures. J. Anim. Sci. 72: 1425-1432.
PMid:8071165
Chakraborty R, Zhong Y, de AM, Clemens PR, et al. (1994). Linkage disequilibria among (CA)n polymorphisms in the human dystrophin gene and their implications in carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophies. Genomics 21: 567-570.
http://dx.doi.org/10.1006/geno.1994.1315
PMid:7959733
Chen H and Leibenguth F (1995). Studies on multilocus fingerprints, RAPD markers, and mitochondrial DNA of a gynogenetic fish (Carassius auratus gibelio). Biochem. Genet. 33: 297-306.
http://dx.doi.org/10.1007/BF02399929
PMid:8748455
Deguchi A, Segawa K, Hosaka K, Weinstein IB, et al. (2002). Overexpression of phosphatidylinositol synthase enhances growth and G1 progression in NIH3T3 cells. Jpn. J. Cancer Res. 93: 157-166.
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01254.x
PMid:11856479
Fu YY, Xiong YZ, Pan G, Cheng L, et al. (2009). Association of the polymorphism of porcine CDIPT gene with carcass and meat quality traits. Chin. J. Anim. Vet. Sci. 40: 787-791.
Hamlin KE, Green RD, Perkins TL, Cundiff LV, et al. (1995). Real-time ultrasonic measurement of fat thickness and longissimus muscle area: I. Description of age and weight effects. J. Anim. Sci. 73: 1713-1724.
PMid:7673065
Lykidis A, Jackson PD, Rock CO and Jackowski S (1997). The role of CDP-diacylglycerol synthetase and phosphatidylinositol synthase activity levels in the regulation of cellular phosphatidylinositol content. J. Biol. Chem. 272: 33402-33409.
http://dx.doi.org/10.1074/jbc.272.52.33402
PMid:9407135
Nei M and Roychoudhury AK (1974). Sampling variances of heterozygosity and genetic distance. Genetics 76: 379-390.
PMid:4822472 PMCid:1213072
Nei M and Li WH (1979). Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc. Natl. Acad. Sci. U. S. A. 76: 5269-5273.
http://dx.doi.org/10.1073/pnas.76.10.5269
PMid:291943 PMCid:413122
Neilson JR and Sandberg R (2010). Heterogeneity in mammalian RNA 3' end formation. Exp. Cell Res. 316: 1357-1364.
http://dx.doi.org/10.1016/j.yexcr.2010.02.040
PMid:20211174 PMCid:2866830
White DA (1973). The Phospholipid Composition of Mammalian Tissues. In: Form and Function of Phospholipids (Ansell GB, Hawthorne JN and Dawson RMC, eds.). Elsevier, Amsterdam, 441-482.
Zhao J, Hyman L and Moore C (1999). Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol. Mol. Biol. Rev. 63: 405-445.
PMid:10357856 PMCid:98971
Zhou JP, Zhu XP, Zhang W, Qin F, et al. (2011). A novel single-nucleotide polymorphism in the 5' upstream region of the prolactin receptor gene is associated with fiber traits in Liaoning cashmere goats. Genet. Mol. Res. 10: 2511-2516.
http://dx.doi.org/10.4238/2011.October.13.8
PMid:22009863
Zimin AV, Delcher AL, Florea L, Kelley DR, et al. (2009). A whole-genome assembly of the domestic cow, Bos taurus. Genome Biol. 10: R42.
http://dx.doi.org/10.1186/gb-2009-10-4-r42
PMid:19393038 PMCid:2688933
“Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies”, vol. 12, pp. 1035-1044, 2013.
, Altinkaya SO, Ugur M, Ceylaner G, Ozat M, et al. (2011). Vascular endothelial growth factor +405 C/G polymorphism is highly associated with an increased risk of endometriosis in Turkish women. Arch. Gynecol. Obstet. 283: 267-272.
http://dx.doi.org/10.1007/s00404-009-1344-1
PMid:20041256
Attar R, Agachan B, Kuran SB, Toptas B, et al. (2010). Genetic variants of vascular endothelial growth factor and risk for the development of endometriosis. In Vivo 24: 297-301.
PMid:20555002
Bhanoori M, Arvind BK, Pavankumar Reddy NG, Lakshmi RK, et al. (2005). The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum. Reprod. 20: 1844-1849.
http://dx.doi.org/10.1093/humrep/deh852
PMid:15746194
Cosin R, Gilabert-Estelles J, Ramon LA, Espana F, et al. (2009). Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression. Fertil. Steril. 92: 1214-1220.
http://dx.doi.org/10.1016/j.fertnstert.2008.08.079
PMid:18930211
Ferrara N (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25: 581-611.
http://dx.doi.org/10.1210/er.2003-0027
PMid:15294883
Ferrara N, Gerber HP and LeCouter J (2003). The biology of VEGF and its receptors. Nat. Med. 9: 669-676.
http://dx.doi.org/10.1038/nm0603-669
PMid:12778165
Fukumura D, Xavier R, Sugiura T, Chen Y, et al. (1998). Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725.
http://dx.doi.org/10.1016/S0092-8674(00)81731-6
Gentilini D, Somigliana E, Vigano P, Vignali M, et al. (2008). The vascular endothelial growth factor +405G>C polymorphism in endometriosis. Hum. Reprod. 23: 211-215.
http://dx.doi.org/10.1093/humrep/dem341
PMid:17977866
Girling JE and Rogers PA (2005). Recent advances in endometrial angiogenesis research. Angiogenesis 8: 89-99.
http://dx.doi.org/10.1007/s10456-005-9006-9
PMid:16211359
Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558.
http://dx.doi.org/10.1002/sim.1186
PMid:12111919
Hsieh YY, Chang CC, Tsai FJ, Yeh LS, et al. (2004). T allele for VEGF gene-460 polymorphism at the 5'-untranslated region: association with a higher susceptibility to endometriosis. J. Reprod. Med. 49: 468-472.
PMid:15283056
Ikuhashi Y, Yoshida S, Kennedy S, Zondervan K, et al. (2007). Vascular endothelial growth factor +936 C/T polymorphism is associated with an increased risk of endometriosis in a Japanese population. Acta Obstet. Gynecol. Scand. 86: 1352-1358.
http://dx.doi.org/10.1080/00016340701644991
PMid:17963063
Kang S, Zhao J, Liu Q, Zhou R, et al. (2009). Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis. Environ. Mol. Mutagen. 50: 361-366.
http://dx.doi.org/10.1002/em.20455
PMid:19197986
Kim JG, Kim JY, Jee BC, Suh CS, et al. (2008). Association between endometriosis and polymorphisms in endostatin and vascular endothelial growth factor and their serum levels in Korean women. Fertil. Steril. 89: 243-245.
http://dx.doi.org/10.1016/j.fertnstert.2007.02.023
PMid:17482599
Kim SH, Choi YM, Choung SH, Jun JK, et al. (2005). Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum. Reprod. 20: 2904-2908.
http://dx.doi.org/10.1093/humrep/dei146
PMid:15979997
Lamp M, Saare M, Laisk T, Karro H, et al. (2010). Genetic variations in vascular endothelial growth factor but not in angiotensin I-converting enzyme genes are associated with endometriosis in Estonian women. Eur. J. Obstet. Gynecol. Reprod. Biol. 153: 85-89.
http://dx.doi.org/10.1016/j.ejogrb.2010.07.021
PMid:20685027
Liu Q, Li Y, Zhao J, Sun DL, et al. (2009a). Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women. Hum. Reprod. 24: 2660-2666.
http://dx.doi.org/10.1093/humrep/dep208
PMid:19531502
Liu Q, Li Y, Zhao J, Zhou RM, et al. (2009b). Association of single nucleotide polymorphisms in VEGF gene with the risk of endometriosis and adenomyosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 26: 165-169.
PMid:19350508
Matalliotakis IM, Katsikis IK and Panidis DK (2005). Adenomyosis: what is the impact on fertility? Curr. Opin. Obstet. Gynecol. 17: 261-264.
http://dx.doi.org/10.1097/01.gco.0000169103.85128.c0
PMid:15870560
Missmer SA and Cramer DW (2003). The epidemiology of endometriosis. Obstet. Gynecol. Clin. North Am. 30: 1-19, vii.
http://dx.doi.org/10.1016/S0889-8545(02)00050-5
Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680.
http://dx.doi.org/10.1001/jama.295.6.676
PMid:16467236
Signorile PG and Baldi A (2010). Endometriosis: new concepts in the pathogenesis. Int. J. Biochem. Cell Biol. 42: 778-780.
http://dx.doi.org/10.1016/j.biocel.2010.03.008
PMid:20230903
Varma R, Rollason T, Gupta JK and Maher ER (2004). Endometriosis and the neoplastic process. Reproduction 127: 293-304.
http://dx.doi.org/10.1530/rep.1.00020
PMid:15016949
Vigano P, Parazzini F, Somigliana E and Vercellini P (2004). Endometriosis: epidemiology and aetiological factors. Best. Pract. Res. Clin. Obstet. Gynaecol. 18: 177-200.
http://dx.doi.org/10.1016/j.bpobgyn.2004.01.007
PMid:15157637
von Elm E, Altman DG, Egger M, Pocock SJ, et al. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370: 1453-1457.
http://dx.doi.org/10.1016/S0140-6736(07)61602-X
Watson CJ, Webb NJ, Bottomley MJ and Brenchley PE (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12: 1232- 1235.
http://dx.doi.org/10.1006/cyto.2000.0692
PMid:10930302
Zhang L, Liu JL, Zhang YJ and Wang H (2011). Association between HLA-B*27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin. Exp. Rheumatol 29: 285-292.
PMid:21418777
Zhao ZZ, Nyholt DR, Thomas S, Treloar SA, et al. (2008). Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis. Mol. Hum. Reprod. 14: 531-538.
http://dx.doi.org/10.1093/molehr/gan043
PMid:18650217
Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137.
http://dx.doi.org/10.1002/gepi.20048
PMid:15593093
“Endothelial nitric oxide synthase gene polymorphisms and essential hypertension in Han Chinese”, vol. 9, pp. 1896-1907, 2010.
, Casas JP, Bautista LE, Humphries SE and Hingorani AD (2004). Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109: 1359-1365.
http://dx.doi.org/10.1161/01.CIR.0000121357.76910.A3
PMid:15007011
Casas JP, Cavalleri GL, Bautista LE, Smeeth L, et al. (2006). Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 164: 921-935.
http://dx.doi.org/10.1093/aje/kwj302
PMid:17018701
Dosh SA (2002). The treatment of adults with essential hypertension. J. Fam. Pract. 51: 74-80.
PMid:11927069
Forte P, Copland M, Smith LM, Milne E, et al. (1997). Basal nitric oxide synthesis in essential hypertension. Lancet 349: 837-842.
http://dx.doi.org/10.1016/S0140-6736(96)07631-3
Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558.
http://dx.doi.org/10.1002/sim.1186
PMid:12111919
Huang HB, Lin LX and Chen MQ (2002). Association of polymorphism of endothelial nitric oxide synthase gene with essential hypertension and type 2 diabetes mellitus. Chin. J. Endocrinol. Metab. 18: 16-19.
Huang PL, Huang Z, Mashimo H, Bloch KD, et al. (1995). Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242.
http://dx.doi.org/10.1038/377239a0
PMid:7545787
Li DB, Hua Q, Pi L, Zou HQ, et al. (2003). Association of polymorphism of endothelial nitric oxide synthase gene with essential hypertension. Chin. J. Hypertens. 11: 552-554.
Li DB, Hua Q and Pi L (2004). Association of G894T polymorphism of endothelial nitric oxide synthase gene and essential hypertension. Chin. J. Hypertens. 12: 326-330.
Li DB, Hua Q and Pi L (2006). The relationship of T786C polymorphism of endothelial nitric oxide synthase gene to essential hypertension. J. Cap. Univ. Med. Sci. 27: 226-229.
Li DJ, Wu WF, Xu L, Jiang XB, et al. (2009). Effect of G894T mutation in the endothelial nitric oxide synthase gene and abnormality of waist-to-hip ratio on essential hypertension. Chin. Gen. Pract. 12: 1173-1175, 1178.
Liang Q, Yang XY, Yang G and Cui JH (2006). Association of angiotensinogen and endothelial nitric oxide synthase gene polymorphism with essential hypertension. J. Youjiang Med. Col. Nationalities 28: 341-343.
Liu HZ and Ha DW (2002). Relationship between 894G→T polymorphism of endothelial nitric oxide synthase gene and essential hypertension. J. Chin. Circ. 17: 42-44.
Ma HX, Xie ZX, Niu YH, Li ZY, et al. (2006). Single nucleotide polymorphisms in NOS3 A-922G, T-786C and G894T: a correlation study of the distribution of their allelic combinations with hypertension in Chinese Han population. Yi. Chuan 28: 3-10.
PMid:16469708
Macaskill P, Walter SD and Irwig L (2001). A comparison of methods to detect publication bias in meta-analysis. Stat. Med. 20: 641-654.
http://dx.doi.org/10.1002/sim.698
PMid:11223905
Mayer B and Hemmens B (1997). Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 22: 477-481.
http://dx.doi.org/10.1016/S0968-0004(97)01147-X
Miyahara K, Kawamoto T, Sase K, Yui Y, et al. (1994). Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur. J. Biochem. 223: 719-726.
http://dx.doi.org/10.1111/j.1432-1033.1994.tb19045.x
PMid:7519987
Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, et al. (1998). Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32: 3-8.
http://dx.doi.org/10.1161/01.HYP.32.1.3
PMid:9674630
Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, et al. (2008). Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension. Free Radic. Biol. Med. 44: 1912-1918.
http://dx.doi.org/10.1016/j.freeradbiomed.2008.02.004
PMid:18325347
Newhouse SJ, Wallace C, Dobson R, Mein C, et al. (2005). Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British genetics of hypertension study. Hum. Mol. Genet. 14: 1805-1814.
http://dx.doi.org/10.1093/hmg/ddi187
PMid:15888480
Niu WQ, Qi Y, Zhang LT, Qi YX, et al. (2009). Endothelial nitric oxide synthase genetic variation and essential hypertension risk in Han Chinese: the Fangshan study. J. Hum. Hypertens. 23: 136-139.
http://dx.doi.org/10.1038/jhh.2008.111
PMid:18769442
Pereira TV, Rudnicki M, Cheung BM, Baum L, et al. (2007). Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J. Hypertens. 25: 1763-1774.
http://dx.doi.org/10.1097/HJH.0b013e3281de740d
PMid:17762636
Schmidt HH and Walter U (1994). NO at work. Cell 78: 919-925.
http://dx.doi.org/10.1016/0092-8674(94)90267-4
Tan JC, Zhu ZM, Zhu SJ, Yu CQ, et al. (2003). The GNB3 and eNOS gene polymorphisms in patients with essential hypertension. Chin. J. Cardiol. 31: 16-19.
Tang JL (2005). Selection bias in meta-analyses of gene-disease associations. PLoS. Med. 2: e409.
http://dx.doi.org/10.1371/journal.pmed.0020409
PMid:16363911 PMCid:1285067
Thaha M, Pranawa, Yogiantoro M, Sutjipto, et al. (2008). Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin. Nephrol. 70: 144-154.
PMid:18793530
Thomas GD, Zhang W and Victor RG (2001). Nitric oxide deficiency as a cause of clinical hypertension: promising new drug targets for refractory hypertension. JAMA 285: 2055-2057.
http://dx.doi.org/10.1001/jama.285.16.2055
PMid:11311074
Tobias A (1999). Assessing the influence of a single study in the meta-analysis estimate. Stata Tech. Bull. 8: 15-17.
Trikalinos TA, Salanti G, Khoury MJ and Ioannidis JP (2006). Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am. J. Epidemiol. 163: 300-309.
http://dx.doi.org/10.1093/aje/kwj046
PMid:16410351
Tsukada T, Yokoyama K, Arai T, Takemoto F, et al. (1998). Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 245: 190-193.
http://dx.doi.org/10.1006/bbrc.1998.8267
PMid:9535806
Wu XF and Huang QY (2009). The a/b polymorphism in the eNOS gene is associated with essential hypertension but not type 2 diabetes in hubei Han Chinese. Prog. Mod. Biomed. 9: 69-72.
Yuan H, Li QX, Ping YH and Liu GZ (2007). Polymorphisms of endothelial nitric oxide synthase NOS3 4a/b and HindIII restriction site of the Y-chromosome in essential hypertension. Chin. J. Lab. Med. 30: 392-394.
Zhao Q, Su SY, Chen SF, Li B, et al. (2006). Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chin Med. J. 119: 1065-1071.
Zhao XY, Guo X, Qiu CC, Zhang DH, et al. (2005). Relationship of endothelial nitric oxide synthase gene polymorphism, the 27-bp repeat in intron 4 with essential hypertension of the northern Han nationality in China. Chin. J. Rehabil. Theory Pract. 11: 422-424.
Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137.
http://dx.doi.org/10.1002/gepi.20048
PMid:15593093
Zintzaras E and Lau J (2008). Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J. Clin. Epidemiol. 61: 634-645.
http://dx.doi.org/10.1016/j.jclinepi.2007.12.011
PMid:18538260
Zintzaras E, Kitsios G and Stefanidis I (2006). Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 48: 700-710.
http://dx.doi.org/10.1161/01.HYP.0000238124.91161.02
PMid:16940230